Boris Johnson Convinced That COVID-19 Was Made in Chinese Lab
October 4, 2024
Zimbabwe to Cull 200 Wild Elephants to Feed Communities Facing Severe Hunger During Drought
October 4, 2024

U.S. Federal Court Revives Hundreds of Lawsuits Over Osteoporosis Drug

News

A U.S. appeals court has reinstated more than 500 lawsuits against drugmaker Merck & Co. because of its osteoporosis drug Fosamax, a bisphosphonate medication, which plaintiffs allege increases risk of thigh bone fractures.
[Source: beckershospitalreview.com]

[Image source: Adobe Stock]

Comment

Despite being used by conventional medicine as a standard treatment for osteoporosis, it has been known since at least 2017 that bisphosphonate drugs can actually make bones weaker. In a study carried out by scientists at Imperial College in London, use of these medications was found to be associated with the development of ‘microcracks’ in bone. Significantly, the bones of patients taking the drugs had a larger number of such cracks and less mechanical strength than those who weren’t.

The Imperial College study examined bone samples from 16 osteoporosis patients aged between 60 and 90 years old. All the patients had previously suffered a broken hip, and half of them had been taking bisphosphonates. The study results revealed that the bones of people taking the drugs had 24 percent more microcracks than those not taking them. Notably, they also had 54 percent more such damage than healthy ageing bone.

To check out Dr. Rath’s Cellular Health recommendations for achieving and maintaining healthy bones, see this page on our website.

Share this post: